Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic® for Beta-thalassemia
RICHMOND, Calif., May 24, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted the Company a $6.4 million...
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer CAMBRIDGE, Mass., May 22, 2013 /PRNewswire/ -- Moderna Therapeutics, the pioneering company developing messenger...
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer Dr. Olson's Extensive Experience in Personalized Medicine Will Support Syros' Mission to Lead in Gene Control...
Ohr Pharmaceutical (OHRP) Appoints June S. Almenoff to Board of Directors
Ohr Pharmaceutical (OHRP) Appoints June S. Almenoff to Board of Directors NEW YORK, May 22, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the...
Precious Metal Recovery Specialist, PhosphonicS, Appoints Linda Bell as CEO
Precious Metal Recovery Specialist, PhosphonicS, Appoints Linda Bell as CEO (Oxford, UK, 20 May 2013) PhosphonicS Ltd, a leading precious metal recovery specialist, today announced the appointment of...
Elite Pharmaceuticals Announces Change in Executive Leadership
Elite Pharmaceuticals Announces Change in Executive Leadership NORTHVALE, N.J., May 21, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company")...
NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer
NW Bio Exhibit Will Describe DCVax Technology and Clinical Trial Progress at Annual Meeting of Over 25,000 Oncologists
BETHESDA, Md.
Merck Provides Update on Phase III Clinical Program for Preladenant, the Company's Investigational Parkinson's Disease Medicine
Release Date: Thursday, May 23, 2013 5:00 pm EDT
Dateline City: WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE [4])--Merck (NYSE: MRK), known as MSD outside the...
Piper Jaffray Expands Healthcare Investment Banking, Appoints Head of West Coast Biotechnology
Piper Jaffray Expands Healthcare Investment Banking, Appoints Head of West Coast Biotechnology MINNEAPOLIS--(BUSINESS WIRE)--Piper Jaffray (NYSE: PJC), a leading investment bank and asset management...
BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to National Institutes of Health (NIH) National Heart, Lung and Blood Institute
BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to National Institutes of Health (NIH) National Heart, Lung and Blood Institute ROCKVILLE, Md. and BALTIMORE, May 20, 2013...
Antares Pharma, Inc. (AIS) Welcomes Marvin Samson to Board of Directors
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the election of Marvin Samson to the Company's Board of Directors. Mr. Samson is an expert in injectable...
ACT Appoints Edward Myles as Chief Financial Officer
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. ("ACT"; OTCQB: ACTC), a leader in the field of regenerative medicine, today announced the appointment of Edward...
Halozyme Therapeutics, Inc. (HALO) Names David A. Ramsay Chief Financial Officer
SAN DIEGO, May 23, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of David A. Ramsay as Chief Financial Officer. Mr. Ramsay was most recently Vice...
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
Celgene International Sàrl, a subsidiary of Celgene Corporation (Celgene) (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review...
Cardeas Pharma Completes $34 Million in Series B Financing
Seattle, May 22, 2013 - Cardeas Pharma Corporation, a biopharmaceutical company focused on the development of innovative therapies for the treatment of multi-drug resistant (MDR) bacterial...
Acquisition of EKOS
23 May 2013 BTG PLC ACQUISITION OF EKOS A fast-growing and profitable interventional vascular business BTG plc (BTG or the Company), the specialist healthcare company, is pleased to announce that it...
BTG PLC Proposed Acquisition of Therasphere
23 May 2013 BTG PLC PROPOSED ACQUISITION OF THERASPHERE(R) Creating a leading Interventional Oncology business and accelerating BTG's Interventional Medicine strategy Introduction BTG plc (BTG),...
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer – Addition of Renowned Scientist Underscores Commitment to Vibrant and Innovative Scientific Research – WESTON,...
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
– Addition of Renowned Scientist Underscores Commitment to Vibrant and Innovative Scientific Research –
Tufts CSDD Study Finds Adoption of Adaptive Clinical Trial Designs Is Increasing
Aptiv Solutions, a biopharmaceutical and medical device development services company and pioneer in adaptive clinical trial design, simulation and execution, announces publication of a Tufts Center
